FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
Global - North America
Archived
•
August 1, 2026
•
5 views
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
Source: NPR News | https://feeds.npr.org/1001/rss.xml - Read Original
"Adventure is where you chose to go."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"What you put in is not always what you get out."
